Aessoa Shine with Lidocaine (1x1ml)
Aessoa
Dermal FillerHyaluronic Acid Skinbooster / Superficial Dermal Filler with Lidocaine
Certifications
- CE Marked hyaluronic acid dermal filler / medical device.
- Manufactured under Good Manufacturing Practice (GMP).
- Manufactured within an ISO 13485 Compliant quality management system for medical devices.
- Professional Use, prescription Only status in some markets in line with local regulations.
- CE Marked hyaluronic acid dermal filler / medical device.
- Manufactured under Good Manufacturing Practice (GMP).
- Manufactured within an ISO 13485 Compliant quality management system for medical devices.
- Professional Use, prescription Only status in some markets in line with local regulations.
Hyaluronic Acid Skinbooster / Superficial Dermal Filler with Lidocaine
Description
Aessoa Shine with Lidocaine (1x1ml) is a monophasic, cross-linked hyaluronic acid dermal filler designed to function like a powerful skinbooster for full-face rejuvenation. Developed by Oreon Life Science under the Aessoa range, it is formulated for injection into the superficial dermis to deeply hydrate the skin, visibly tighten pores, and smooth fine lines while improving overall tone, texture, and radiance. Containing 24 mg/ml hyaluronic acid and 3 mg/ml lidocaine (0.3%), Aessoa Shine delivers comfortable treatment with minimal pain. It is suitable for treating superficial lines, fine wrinkles, nasolabial folds and marionette lines, as well as enhancing lip volume and subtly reshaping the nose, giving a luminous, youthful glow that typically lasts up to 12–18 months.
Bnefits
- Deeply hydrates the skin for long-lasting moisture and improved elasticity.
- Fills and softens superficial lines and fine wrinkles on the face and neck.
- Visibly tightens and refines pores, creating a smoother, more airbrushed appearance.
- Enhances overall skin tone, texture, and radiance for a luminous glow.
- Can be used to add subtle lip volume and enhance lip contours.
- Allows gentle nose reshaping and contour refinement in suitable candidates.
- Monophasic, soft, homogeneous gel for smooth, even injection and distribution.
- Contains lidocaine for improved patient comfort and reduced injection pain.
- Designed for full-face use in the superficial dermis (face and often neck).
- Provides generally long-lasting results, typically 12–18 months, depending on patient and treatment area.
Indications
- Superficial facial lines and fine wrinkles.
- Skin dehydration and loss of radiance.
- Enlarged or visible facial pores requiring tightening and refinement.
- Nasolabial folds (mild to moderate) and marionette lines.
- Horizontal neck lines and superficial neck wrinkles (where clinically appropriate).
- Overall facial rejuvenation and skin quality improvement.
- Subtle lip volume enhancement and contour definition.
- Subtle nose reshaping and contour correction (non-surgical rhinoplasty) in suitable patients.
- Use in the superficial dermis where a soft, hydrating filler or skinbooster-type effect is desired.
Composition
- Cross-linked hyaluronic acid: 24 mg/ml (monophasic gel, non-animal origin).
- Lidocaine hydrochloride: 3 mg/ml (0.3%) as a local anaesthetic.
- Physiological buffer and excipients (q.s.), as specified in the manufacturer’s instructions for use.
Formulation
- Monophasic, cross-linked hyaluronic acid gel with a soft, homogeneous consistency.
- Designed for injection into the superficial dermis as a skinbooster-like dermal filler.
- High concentration of hyaluronic acid to support hydration, elasticity, and radiance.
- Contains lidocaine to increase patient comfort during treatment.
- Sterile, pyrogen-free, non-animal derived hyaluronic acid formulation.
Packaging
- 1 x 1 ml pre-filled glass syringe of Aessoa Shine with Lidocaine per box.
- No needles included in most distributor packs; a 27G needle is commonly recommended.
- Syringe with Luer-lock connection for compatibility with standard needles and cannulas.
- Each syringe supplied in an individual sterile blister pack within an outer carton.
- Carton and blister labelled with product name, batch number, and expiry date.
- Single-use, sterile medical device intended for professional use only.
Usage
- For professional use only; injections must be carried out by suitably trained and licensed healthcare practitioners experienced in facial anatomy and dermal filler techniques.
- Obtain a full medical history and assess indications, contraindications, and patient expectations before treatment; obtain informed consent in line with local regulations.
- Cleanse and disinfect the treatment area using appropriate antiseptic measures prior to injection.
- Aessoa Shine is designed to be injected into the superficial dermis of the skin.
- Use an appropriate needle (commonly 27G) or microcannula according to the treatment plan and manufacturer/distributor recommendations.
- Inject slowly using low, controlled pressure, with frequent aspiration and adherence to safe injection practices to minimise the risk of intravascular injection.
- Distribute the product evenly using suitable techniques (e.g. linear threading, micro-bolus, fanning) depending on indication and area treated.
- Avoid overcorrection; account for initial swelling and the hydrophilic nature of hyaluronic acid when deciding on volume.
- After injection, gently massage the treated area if needed to ensure smooth contour and even product distribution.
- Advise patients on standard post-treatment care: avoid makeup on the treated area for several hours, avoid extreme heat/cold, strenuous exercise, and alcohol for 24 hours, and avoid facials or energy-based treatments over the area for the period recommended by the practitioner.
- A follow-up assessment may be scheduled after 2–4 weeks to evaluate the result and determine whether any touch-up is required.
Contraindications
- Hypersensitivity or allergy to hyaluronic acid.
- Known hypersensitivity or allergy to lidocaine or other amide-type local anaesthetics.
- History of severe allergic reactions or anaphylaxis to injectable fillers or any component of the product.
- Active skin infections, inflammatory skin conditions, or lesions (e.g. acne, herpes, dermatitis) at or near the intended injection sites.
- Current systemic infection or uncontrolled systemic disease where injectable aesthetic treatment may pose additional risk, according to clinician judgment.
- Patients with bleeding disorders or on significant anticoagulant or antiplatelet therapy where the risk of bleeding or haematoma is unacceptable, unless assessed and managed by the prescribing clinician.
- Pregnant or breastfeeding patients (use is generally not recommended due to lack of safety data).
- Patients under 18 years of age or below the legally permitted age for aesthetic treatments in the relevant jurisdiction.
- Injection into vascular structures or intravascular injection is strictly contraindicated.
- Use in areas with compromised tissue viability, severe scarring, or permanent implants, unless specifically assessed and deemed appropriate by the treating clinician.
Adverse Effects
- Common, usually mild and transient injection-site reactions: redness, swelling, tenderness, pain, itching, bruising, or induration.
- Temporary oedema in the treated area, particularly in more vascular regions such as lips and periorbital areas.
- Small lumps or nodules at the injection site or along the injection track, typically resolving with massage or conservative management.
- Transient asymmetry or irregularity related to injection technique or post-procedural swelling.
- Rare inflammatory reactions or hypersensitivity, including prolonged swelling, firmness, or delayed inflammatory nodules.
- Rare but serious complications typical of hyaluronic acid fillers, including vascular occlusion, ischaemia, and potential tissue necrosis if product is inadvertently injected into or compresses a blood vessel.
- Very rare risk of visual disturbance or blindness with inadvertent intravascular injection in high-risk anatomical zones.
- As with all injectable procedures, there is a risk of infection if aseptic technique is not strictly followed.
- Any severe, persistent, or unexpected adverse effects should be evaluated and managed according to local clinical protocols, which may include use of hyaluronidase and/or urgent medical referral.
Storage Conditions
- Store at a controlled room temperature in line with the manufacturer’s instructions (typically between 2°C and 25°C).
- Protect from direct sunlight, heat sources, and excessive moisture.
- Do not freeze the product.
- Keep the syringe in its original blister and carton until immediately before use to maintain sterility and protect from light.
- Do not use the product after the expiry date indicated on the packaging.
- Do not use if the sterile blister or outer packaging is damaged or previously opened.
- Store out of the reach of children and unauthorised persons.
Duration
Clinical results commonly last approximately 12\u201318 months, depending on factors such as treatment area, injection technique, product volume, patient metabolism, lifestyle, and skin quality.
Onset
Visible improvement is usually immediate following injection, with enhanced hydration, tightening, and radiance becoming more evident over the subsequent days as any initial swelling subsides.
